Subgroup | N | HR (95% CI) | P value | P (interaction) |
AMI group | 0.9974 | |||
STEMI | 1108 | 1.09 (0.32 to 3.74) | 0.8897 | |
Non-STEMI | 1443 | 1.38 (0.47 to 4.03) | 0.5529 | |
Myocardial infarction type 2 | 621 | 1.03 (0.30 to 3.56) | 0.9592 | |
Subendocardial infarction | 1737 | 1.19 (0.37 to 3.78) | 0.7697 | |
other | 158 | 1.34 (0.03 to 69.75) | 0.8846 |
Risk factor: RPR.
Outcome variable: hospital mortality.
Stratification adjusted for: age, weight, ethnicity, hyperlipdaemia, Charlson Comorbidity Index. HAS-BLED: a recently developed and validated scoring system to assess bleeding risk in patients with atrial fibrillation (AF) who are receiving anticoagulant therapy, Creatinine.
AMI, acute myocardial infarction; RPR, red cell distribution width-to-platelet ratio; STEMI, ST-segment elevated myocardial infarction.